GARRITY THOMAS J
Insider CIK 1275012 · AIS Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ATRS ANTARES PHARMA, INC. | D To issuer deriv | 2022-05-24 | 2022-05-26 | 76,548 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | D To issuer deriv | 2022-05-24 | 2022-05-26 | 58,246 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | D To issuer deriv | 2022-05-24 | 2022-05-26 | 46,729 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | D To issuer deriv | 2022-05-24 | 2022-05-26 | 48,542 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | D To issuer deriv | 2022-05-24 | 2022-05-26 | 80,318 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | D To issuer deriv | 2022-05-24 | 2022-05-26 | 99,395 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | D To issuer deriv | 2022-05-24 | 2022-05-26 | 61,930 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | D To issuer | 2022-05-24 | 2022-05-26 | 224,406 | $5.60 | $1.26M | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | D To issuer | 2022-05-24 | 2022-05-26 | 25,452 | $5.60 | $142.5K | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award deriv | 2021-06-10 | 2021-06-14 | 48,542 | — | $0 | 48,542 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award | 2021-06-10 | 2021-06-14 | 25,452 | $4.42 | $112.5K | 249,858 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise deriv | 2021-03-11 | 2021-03-12 | 50,000 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise | 2021-03-11 | 2021-03-12 | 50,000 | $1.12 | $56.0K | 274,406 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | S Sale | 2021-03-11 | 2021-03-12 | 50,000 | $4.28 | $214.0K | 224,406 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise deriv | 2021-02-11 | 2021-02-12 | 50,000 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise | 2021-02-11 | 2021-02-12 | 50,000 | $1.12 | $56.0K | 274,406 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | S Sale | 2021-02-11 | 2021-02-12 | 50,000 | $4.62 | $231.0K | 224,406 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise deriv | 2021-01-11 | 2021-01-13 | 50,000 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise deriv | 2021-01-11 | 2021-01-13 | 20,000 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | S Sale | 2021-01-11 | 2021-01-13 | 50,000 | $4.05 | $202.5K | 224,406 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise | 2021-01-11 | 2021-01-13 | 20,000 | $2.24 | $44.8K | 244,406 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | S Sale | 2021-01-11 | 2021-01-13 | 20,000 | $4.07 | $81.4K | 224,406 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise | 2021-01-11 | 2021-01-13 | 50,000 | $1.12 | $56.0K | 274,406 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award deriv | 2020-06-11 | 2020-06-15 | 58,246 | — | $0 | 58,246 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award | 2020-06-11 | 2020-06-15 | 30,220 | $2.73 | $82.5K | 224,406 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise deriv | 2019-12-09 | 2019-12-11 | 40,000 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise deriv | 2019-12-09 | 2019-12-11 | 40,000 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise | 2019-12-09 | 2019-12-11 | 40,000 | $1.60 | $64.0K | 234,186 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | S Sale | 2019-12-09 | 2019-12-11 | 40,000 | $4.58 | $183.2K | 194,186 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise | 2019-12-09 | 2019-12-11 | 40,000 | $1.66 | $66.4K | 234,186 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | S Sale | 2019-12-09 | 2019-12-11 | 40,000 | $4.58 | $183.2K | 194,186 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise deriv | 2019-11-01 | 2019-11-04 | 10,000 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise | 2019-11-01 | 2019-11-04 | 10,000 | $1.10 | $11.0K | 194,186 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award deriv | 2019-06-13 | 2019-06-14 | 46,729 | — | $0 | 46,729 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award | 2019-06-13 | 2019-06-14 | 23,973 | $2.92 | $70.0K | 184,186 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise deriv | 2019-05-01 | 2019-05-03 | 30,000 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise | 2019-05-01 | 2019-05-03 | 30,000 | $0.53 | $15.9K | 190,213 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | S Sale | 2019-05-01 | 2019-05-03 | 30,000 | $2.67 | $80.1K | 160,213 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award deriv | 2018-06-08 | 2018-06-11 | 76,548 | — | $0 | 76,548 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise deriv | 2017-10-03 | 2017-10-05 | 30,000 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise | 2017-10-03 | 2017-10-05 | 30,000 | $0.85 | $25.5K | 190,213 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | S Sale | 2017-10-03 | 2017-10-05 | 30,000 | $3.50 | $105.0K | 160,213 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award deriv | 2017-06-07 | 2017-06-09 | 80,318 | — | $0 | 80,318 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise deriv | 2017-03-31 | 2017-04-04 | 30,000 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | S Sale | 2017-03-31 | 2017-04-04 | 30,000 | $2.91 | $87.3K | 160,213 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise | 2017-03-31 | 2017-04-04 | 30,000 | $1.65 | $49.5K | 190,213 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award deriv | 2016-06-02 | 2016-06-06 | 150,000 | — | $0 | 150,000 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | P Buy | 2016-03-18 | 2016-03-21 | 30,000 | $0.72 | $21.6K | 160,213 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award deriv | 2015-05-28 | 2015-06-01 | 99,395 | — | $0 | 99,395 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | P Buy | 2014-08-11 | 2014-08-13 | 5,000 | $1.98 | $9.9K | 130,213 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award deriv | 2014-05-29 | 2014-06-02 | 61,930 | — | $0 | 261,930 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | S Sale | 2013-05-31 | 2013-06-03 | 13,000 | $4.08 | $53.0K | 125,213 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | A Award | 2013-05-22 | 2013-05-24 | 27,778 | — | $0 | 138,213 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise deriv | 2012-08-20 | 2012-08-22 | 500 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise deriv | 2012-08-20 | 2012-08-22 | 18,000 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise deriv | 2012-08-20 | 2012-08-22 | 500 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise deriv | 2012-08-20 | 2012-08-22 | 2,000 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise deriv | 2012-08-20 | 2012-08-22 | 1,000 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise deriv | 2012-08-20 | 2012-08-22 | 500 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise deriv | 2012-08-20 | 2012-08-22 | 2,000 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise deriv | 2012-08-20 | 2012-08-22 | 500 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise deriv | 2012-08-20 | 2012-08-22 | 500 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise deriv | 2012-08-20 | 2012-08-22 | 6,750 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise deriv | 2012-08-20 | 2012-08-22 | 10,000 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise deriv | 2012-08-20 | 2012-08-22 | 20,000 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise deriv | 2012-08-20 | 2012-08-22 | 20,000 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise deriv | 2012-08-20 | 2012-08-22 | 1,250 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise deriv | 2012-08-20 | 2012-08-22 | 1,250 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise deriv | 2012-08-20 | 2012-08-22 | 1,000 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise deriv | 2012-08-20 | 2012-08-22 | 2,000 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise deriv | 2012-08-20 | 2012-08-22 | 500 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise deriv | 2012-08-20 | 2012-08-22 | 500 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise deriv | 2012-08-20 | 2012-08-22 | 2,000 | — | $0 | 0 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise | 2012-08-20 | 2012-08-22 | 500 | $1.45 | $725 | 102,295 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | F Tax w/h | 2012-08-20 | 2012-08-22 | 335 | $3.97 | $1.3K | 101,795 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise | 2012-08-20 | 2012-08-22 | 1,000 | $1.33 | $1.3K | 102,130 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | F Tax w/h | 2012-08-20 | 2012-08-22 | 554 | $3.97 | $2.2K | 101,130 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise | 2012-08-20 | 2012-08-22 | 2,000 | $1.10 | $2.2K | 101,684 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | F Tax w/h | 2012-08-20 | 2012-08-22 | 134 | $3.97 | $532 | 99,684 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise | 2012-08-20 | 2012-08-22 | 500 | $1.06 | $530 | 99,818 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | F Tax w/h | 2012-08-20 | 2012-08-22 | 166 | $3.97 | $659 | 103,741 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise | 2012-08-20 | 2012-08-22 | 18,000 | $1.06 | $19.1K | 104,124 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | F Tax w/h | 2012-08-20 | 2012-08-22 | 142 | $3.97 | $564 | 86,124 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise | 2012-08-20 | 2012-08-22 | 500 | $1.13 | $565 | 86,266 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | F Tax w/h | 2012-08-20 | 2012-08-22 | 188 | $3.97 | $746 | 85,766 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise | 2012-08-20 | 2012-08-22 | 500 | $1.49 | $745 | 85,954 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | F Tax w/h | 2012-08-20 | 2012-08-22 | 2,210 | $3.97 | $8.8K | 85,454 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise | 2012-08-20 | 2012-08-22 | 6,750 | $1.30 | $8.8K | 87,664 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | F Tax w/h | 2012-08-20 | 2012-08-22 | 183 | $3.97 | $727 | 102,112 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise | 2012-08-20 | 2012-08-22 | 2,000 | $1.40 | $2.8K | 104,112 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | F Tax w/h | 2012-08-20 | 2012-08-22 | 705 | $3.97 | $2.8K | 103,407 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise | 2012-08-20 | 2012-08-22 | 500 | $1.32 | $660 | 103,907 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | F Tax w/h | 2012-08-20 | 2012-08-22 | 4,806 | $3.97 | $19.1K | 99,318 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise | 2012-08-20 | 2012-08-22 | 500 | $0.96 | $480 | 105,732 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | F Tax w/h | 2012-08-20 | 2012-08-22 | 509 | $3.97 | $2.0K | 105,232 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise | 2012-08-20 | 2012-08-22 | 2,000 | $1.01 | $2.0K | 105,741 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | F Tax w/h | 2012-08-20 | 2012-08-22 | 3,904 | $3.97 | $15.5K | 141,435 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise | 2012-08-20 | 2012-08-22 | 10,000 | $1.55 | $15.5K | 145,339 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | F Tax w/h | 2012-08-20 | 2012-08-22 | 7,758 | $3.97 | $30.8K | 135,339 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise | 2012-08-20 | 2012-08-22 | 20,000 | $1.54 | $30.8K | 143,097 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | F Tax w/h | 2012-08-20 | 2012-08-22 | 7,053 | $3.97 | $28.0K | 123,097 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise | 2012-08-20 | 2012-08-22 | 20,000 | $1.40 | $28.0K | 130,150 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | F Tax w/h | 2012-08-20 | 2012-08-22 | 441 | $3.97 | $1.8K | 110,150 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise | 2012-08-20 | 2012-08-22 | 1,250 | $1.40 | $1.8K | 110,591 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | F Tax w/h | 2012-08-20 | 2012-08-22 | 220 | $3.97 | $873 | 109,341 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise | 2012-08-20 | 2012-08-22 | 1,250 | $0.70 | $875 | 109,561 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | F Tax w/h | 2012-08-20 | 2012-08-22 | 227 | $3.97 | $901 | 108,311 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise | 2012-08-20 | 2012-08-22 | 1,000 | $0.90 | $900 | 108,538 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | F Tax w/h | 2012-08-20 | 2012-08-22 | 453 | $3.97 | $1.8K | 107,538 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise | 2012-08-20 | 2012-08-22 | 2,000 | $0.90 | $1.8K | 107,991 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | F Tax w/h | 2012-08-20 | 2012-08-22 | 120 | $3.97 | $476 | 105,991 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | M Exercise | 2012-08-20 | 2012-08-22 | 500 | $0.95 | $475 | 106,111 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | F Tax w/h | 2012-08-20 | 2012-08-22 | 121 | $3.97 | $480 | 105,611 | SEC↗ |
| ATRS ANTARES PHARMA, INC. | S Sale | 2012-08-20 | 2012-08-22 | 31,000 | $4.02 | $124.6K | 110,435 | SEC↗ |
| AIS ANTARES PHARMA, INC. | A Award | 2012-05-17 | 2012-05-21 | 30,914 | — | $0 | 80,914 | SEC↗ |